News Release

 

 

LGTmedical launches Kenek Edge

mobile pulse oximeter at

Life Science Innovation Northwest 2014

Unique Kenek Core™ platform utilizes the audio jack to connect standard sensors to mobile devices.

SEATTLE – June 20, 2014 - LionsGate Technologies Inc. (LGTmedical) announces the Kenek Edge mobile pulse oximeter today at Life Science Innovation Northwest 2014, North America’s largest, fully-integrated life science expo.

The Kenek Edge pulse oximeter measures vital signs by connecting to supported mobile phones and tablets through the audio port. An external fingertip sensor shines light through tissue to measure a person’s blood oxygen level and heart rate quickly, easily, and accurately. The feature-packed Kenek Edge pulse oximeter will be available for purchase on June 27, 2014.

“Our devices are based on our novel and universal audio-based interface, Kenek Core™, which enables standard sensors to connect to mobile devices to provide ultra-low cost vital signs monitoring,” said Tom Walker, President and CEO of LGTmedical. “The Kenek Core platform utilizes the audio jack found on smartphones and tablets to provide universal access for almost any type of sensor.”

The Kenek Edge prototype was the Phone Oximeter™ app and sensor developed in 2010 by scientists Drs. Mark Ansermino, Guy Dumont, and Peter von Dadelszen at the University of British Columbia (UBC) in Vancouver, Canada.

After initial funding from the Bill & Melinda Gates Foundation, this innovation was awarded a seed grant in 2011 by Saving Lives at Birth, a partnership between Grand Challenges Canada, the US Agency for International Development (USAID), the UK Department for International Development, the Government of Norway, and the Bill & Melinda Gates Foundation.

Developed for the global health market, the Phone Oximeter enables the identification of pregnant women in the developing world who are at risk of life-threatening complications due to high blood pressure known as preeclampsia, one of the leading causes of maternal mortality. It also supports the diagnosis of pneumonia, the leading killer of children under the age of five in the developing world.

As a socially driven business, pulse oximetry is LGTmedical’s initial application to be commercialized. The clinical impact of diagnosis and treatment through pulse oximetry increases dramatically in resource-limited regions but accessibility and affordability are key barriers to adoption worldwide.

LGTmedical’s Kenek Core interface will enable ultra-low cost, high-quality mobile sensors to be available for everyone, everywhere.

About LionsGate Technologies Inc. (LGTmedical)

LGTmedical is a spin-off company of the University of British Columbia (UBC), the Child & Family Research Institute, and BC Children’s Hospital in Vancouver, BC, Canada. It has leveraged the synergies of award-winning interdisciplinary research, global foundations, and business expertise to establish the innovative core technologies, infrastructure, and partnerships and become a leading mHealth company. LGTmedical is focused on product and channel development to achieve the most scalable and clinically impactful global mobile health solutions. The company is ISO 13485:2003 certified.

Kenek, Kenek Core, Kenek Edge, and Phone Oximeter are trademarks of LionsGate Technologies Inc.

Kenek Edge is a mobile application (app) and sensor that can help people manage their own health and wellness, promote healthy living, and gain access to useful information when and where they need it. The information should not be used for medical or clinical purposes.

Media Contact:
Pamela Clarke
Director, Marketing and Communications
LGTmedical
Direct: 604.983.8627
pamela.clarke@lgtmedical.com